Assura PDMRs Acquire Shares Under SIP
Why we think this is neutral
This RNS announcement is a routine regulatory update on director/PDMR shareholding changes, which is common practice and does not have a material financial impact on the business. The acquisition of shares by key management under the company's SIP scheme is a positive sign of their commitment to Assura, but does not significantly alter the investment case.
Key Points
- Assura PDMRs acquired partnership shares and were awarded matching shares and free shares under the company's Share Incentive Plan
- Shareholding changes for CEO, CFO, General Counsel, Group Development Director, Chief People Officer, and Chief Investment Officer
Summary
Assura plc, the UK's leading diversified healthcare REIT, announced that on 5 March 2025, several of its Persons Discharging Managerial Responsibilities (PDMRs) acquired partnership shares and were awarded matching shares and free shares under the company's Share Incentive Plan (SIP). This includes the CEO, CFO, General Counsel, Group Development Director, Chief People Officer, and Chief Investment Officer. The company's portfolio was valued at £2.7 billion as of 30 September 2023 and it is a constituent of the FTSE 250 and EPRA indices. Broker targets range from 48p to 51p with a mix of Buy, Hold, and Add recommendations.